Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
Open Access
- 1 January 2016
- journal article
- review article
- Published by Elsevier in Translational Research
- Vol. 167 (1) , 192-203
Abstract
No abstract availableKeywords
Funding Information
- British Lung Foundation (RG14-10)
- Pfizer (8500205563)
- Asthma UK (08/041)
- Wellcome Trust (085935)
- Medical Research Council (MRC) (G1001367/1)
- University of Ferrara
- AstraZeneca
- Boehringer Ingelheim
- GlaxoSmithKline (GSK)
- MRC (G1001367/1)
- Wellcome Trust (093080/Z/10/Z)
- European Union Innovative Medicines Initiative (EU-IMI) (115010)
- Vivensa Foundation (R368/0714)
- British Heart Foundation (PG/14/27/30679)
- NIHR Respiratory Disease Biomedical Research Unit
- Imperial College London
This publication has 95 references indexed in Scilit:
- Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2013
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE studyRheumatology, 2012
- A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthmaEuropean Respiratory Journal, 2012
- Oxidative Stress–induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patientsClinical and Experimental Immunology, 2009
- New drugs targeting Th2 lymphocytes in asthmaJournal of Occupational Medicine and Toxicology, 2008
- Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroidsProceedings of the National Academy of Sciences, 2007